WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011015617) SOLID FORMS OF AN N-(PHENYLMETHYL)PROPANAMIDE DERIVATIVE AND PROCESSES OF PREPARATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/015617    International Application No.:    PCT/EP2010/061394
Publication Date: 10.02.2011 International Filing Date: 05.08.2010
IPC:
C07C 237/22 (2006.01)
Applicants: MEDICHEM, S.A. [ES/ES]; Fructuós Gelabert, 6-8 Sant Joan Despí E-08970 Barcelona (ES) (For All Designated States Except US).
DURAN LOPEZ, Ernesto [ES/ES]; (ES) (For US Only).
BENITO VELEZ, Monica [ES/ES]; (ES) (For US Only).
BOSCH I LLADÓ, Jordi [ES/ES]; (ES) (For US Only)
Inventors: DURAN LOPEZ, Ernesto; (ES).
BENITO VELEZ, Monica; (ES).
BOSCH I LLADÓ, Jordi; (ES)
Agent: GALLAFENT, Antony, Xavier; Gallafents LLP 27 Britton Street London Greater London EC1M 5UD (GB)
Priority Data:
61/231,936 06.08.2009 US
61/231,932 06.08.2009 US
Title (EN) SOLID FORMS OF AN N-(PHENYLMETHYL)PROPANAMIDE DERIVATIVE AND PROCESSES OF PREPARATION
(FR) FORMES SOLIDES D'UN DÉRIVÉ DE N-(PHÉNYLMÉTHYL)PROPANAMIDE ET LEURS PROCÉDÉS DE PRÉPARATION
Abstract: front page image
(EN)Disclosed are solid Forms, and corresponding mixtures, of the anti-epileptic agent lacosamide (I). Also disclosed is a mixture of lacosamide enantiomers crystallized in a conglomerate Form and the use thereof in providing enantiomerically enriched lacosamide, preferably lacosamide enriched with the (R)- enantiomer of lacosamide.
(FR)L'invention porte sur des formes solides, et des mélanges correspondants, de l'agent antiépileptique lacosamide (I). L'invention porte également sur un mélange d'énantiomères du lacosamide cristallisé en une forme de conglomérat et sur son utilisation pour la production de lacosamide enrichi du point de vue des énantiomères, de préférence de lacosamide enrichi en énantiomère (R) du lacosamide.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)